术中锥形束CT主动脉造影提高支气管动脉栓塞术中责任动脉识别及其临床影响
回顾性比较282例317次支气管动脉栓塞术,B组(术前胸部CTA联合术中CBCT主动脉造影)较A组(仅术前CTA)检出更多起源于锁骨下动脉的非支气管体循环责任动脉(16 vs 3,p=0.026),栓塞血管数更多(2.47±1.61 vs 2.03±1.17,p=0.016),手术时间更短(37.4±22.0 vs 43.6±22.7 min,p=0.024),咯血复发率更低(17.5% vs 8.7%,p=0.041),需后续手术比例更低(12.4% vs 4.8%,p=0.035),肾功能与辐射剂量无显著差异。
要点
- 术中CBCT主动脉造影可检出更多起源于锁骨下动脉的非支气管体循环责任动脉(16 vs 3,p=0.026)。
- B组平均栓塞血管数多于A组(2.47±1.61 vs 2.03±1.17,p=0.016),手术时间更短(37.4±22.0 vs 43.6±22.7 min,p=0.024)。
- B组咯血复发率更低(17.5% vs 8.7%,p=0.041),需后续手术比例更低(12.4% vs 4.8%,p=0.035)。
核心结论
- 与未使用术中CBCT主动脉造影的BAE相比,使用该技术可栓塞更多责任动脉,降低咯血复发率,且不增加肾功能恶化和辐射危害风险。
研究设计与样本
- 回顾性研究,纳入282例患者共317次支气管动脉栓塞术,A组177例(仅术前胸部CTA),B组105例(术前胸部CTA联合术中CBCT主动脉造影)。
关键影像表现/征象
- B组CBCT主动脉造影较胸部CTA检出更多起源于锁骨下动脉的非支气管体循环责任动脉(16 vs 3,p=0.026)。
- B组平均栓塞血管数为2.47±1.61,A组为2.03±1.17(p=0.016)。
- B组手术时间为37.4±22.0 min,A组为43.6±22.7 min(p=0.024)。
诊断标准与关键数值
- B组咯血复发率为8.7%,A组为17.5%(p=0.041)。
- B组需后续手术的患者比例为4.8%,A组为12.4%(p=0.035)。
- 两组术前与术后3天eGFR变化分别为0.1±12.8 vs 0.3±11.0 mL/min/1.73 m2(p=0.909),无显著差异。
- 两组总剂量面积乘积(DAP)分别为6119.5±5725.7 vs 6906.2±5978.6 uGym2(p=0.279),无显著差异。
临床应用与阅片要点
- 术中CBCT主动脉造影可辅助识别起源于锁骨下动脉等部位的非支气管体循环责任动脉。
- 使用CBCT主动脉造影的BAE可增加栓塞血管数并缩短手术时间。
- 该技术不增加肾功能恶化风险及辐射剂量。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the impact of intraprocedural cone-beam CT (CBCT) aortography on culprit artery identification and clinical outcomes in patients undergoing bronchial artery embolization (BAE).
MATERIALS AND METHODS: Two hundred eighty-two patients with 317 BAE procedures were retrospectively reviewed. Patients who underwent preprocedural chest CT angiography (CTA) without intraprocedural CBCT aortography were categorized as Group A (n = 177). Patients who underwent both preprocedural chest CTA and intraprocedural CBCT aortography were categorized as Group B (n = 105). Whether CBCT can provide improved culprit artery identification and whether this improvement has a clinical impact were evaluated by comparing the two Groups.
RESULTS: In Group B, CBCT aortography detected more culprit non-bronchial systemic arteries originating from the subclavian arteries compared to chest CTA (16 vs 3, p = 0.026), and the average number of embolized vessels was significantly higher than in Group A (2.47 ± 1.61 vs 2.03 ± 1.17, p = 0.016), while the procedure time was shorter (37.4 ± 22.0 vs 43.6 ± 22.7 min, p = 0.024). The recurrent hemoptysis rate was lower in Group B (17.5% vs 8.7%, p = 0.041), and the proportion of patients requiring subsequent procedures was significantly lower (12.4% vs 4.8%, p = 0.035). The changes in estimated glomerular filtration rate before and 3 days after the procedure (0.1 ± 12.8 vs 0.3 ± 11.0 mL/min/1.73 m2, p = 0.909) and total dose area product (DAP, 6119.5 ± 5725.7 vs 6906.2 ± 5978.6 uGym2, p = 0.279) were not significantly different between the two groups.
CONCLUSION: BAE with intraprocedural CBCT aortography enabled the embolization of more culprit arteries, leading to lower recurrent hemoptysis rates without increasing the risk of renal deterioration and radiation hazards when compared to procedures without it.
KEY POINTS: Question Does intraprocedural CBCT aortography improve culprit artery detection and clinical outcomes in BAE for hemoptysis? Findings CBCT aortography significantly improved the detection of additional culprit arteries, especially from non-bronchial systemic arteries, increasing the number of vessels treated during BAE. Clinical relevance Using CBCT aortography during BAE results in better long-term outcomes by reducing recurrent hemoptysis and the need for additional procedures, without increasing the risk of renal impairment.
引用
- Shin BK, Kim KY, Han YM, et al. Improving culprit artery identification with intraprocedural cone-beam CT aortography and its clinical impact in bronchial artery embolization. Eur Radiol. 2024. PMID: 39472334. doi:10.1007/s00330-024-11152-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。